15 ML atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection
RxNorm concept 2693892, clinical drug (scd). Prescribable name: atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT in 15 ML Injection.
- RxCUI
- 2693892
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
atezolizumab-hyaluronidase-tqjs 1875 MG / 30,000 UNT per 15 ML Injection
Related concepts
- atezolizumab-tqjs 125 MG/ML (SCDC, consists of)
- hyaluronidase-tqjs 2000 UNT/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 15 ML atezolizumab-tqjs 125 MG/ML / hyaluronidase-tqjs 2000 UNT/ML Injection [Tecentriq Hybreza] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2693892 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693892 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693892. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.